Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × GIST × pazopanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 22 Sarcoma 14 Neoplasm Metastasis 11 Carcinoma, Non-Small-Cell Lung 8 Breast Neoplasms 8 Ovarian Neoplasms 6 Recurrence 5 Neoplasms 5 Melanoma 4 Leiomyosarcoma 4 Urinary Bladder Neoplasms 3 Neuroendocrine Tumors 3 Lung Neoplasms 3 Liposarcoma 3 Hemangiosarcoma 3 Glioblastoma 3 Gastrointestinal Stromal Tumors 3 Fallopian Tube Neoplasms 3 Uterine Cervical Neoplasms 2 Thyroid Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma, Synovial 2 Sarcoma, Alveolar Soft Part 2 Rhabdomyosarcoma 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Kidney Neoplasms 2 Gliosarcoma 2 Clear-cell metastatic renal cell carcinoma 2

Interventions

vandetanib 1 pazopanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01323400 2016-02-25

PAZOGIST

Centre Leon Berard

Phase 2 Completed

GIST

Data powered by HemOnc (CC BY 4.0) Colophon ⚡